262 related articles for article (PubMed ID: 30734695)
1. Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions.
Porco TC; Oldenburg CE; Arzika AM; Kalua K; Mrango Z; Cook C; Lebas E; Bailey RL; West SK; Oron AP; Keenan JD; Lietman TM; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1291-1294. PubMed ID: 30734695
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
[TBL] [Abstract][Full Text] [Related]
3. Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials.
Oldenburg CE; Arzika AM; Amza A; Gebre T; Kalua K; Mrango Z; Cotter SY; West SK; Bailey RL; Emerson PM; O'Brien KS; Porco TC; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2019 Mar; 100(3):691-695. PubMed ID: 30608051
[TBL] [Abstract][Full Text] [Related]
4. One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality.
Tam CC; Offeddu V; Lim JM; Voo TC
J Glob Health; 2019 Jun; 9(1):010305. PubMed ID: 30643634
[No Abstract] [Full Text] [Related]
5. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.
Oldenburg CE; Arzika AM; Maliki R; Lin Y; O'Brien KS; Keenan JD; Lietman TM; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1308-1310. PubMed ID: 32067626
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
[TBL] [Abstract][Full Text] [Related]
7. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM;
PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496
[TBL] [Abstract][Full Text] [Related]
8. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
9. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
10. Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial.
Bloch EM; Mrango Z; Weaver J; Munoz B; Lietman TM; West SK
PLoS One; 2021; 16(9):e0250197. PubMed ID: 34559801
[TBL] [Abstract][Full Text] [Related]
11. Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
Porco TC; Hart J; Arzika AM; Weaver J; Kalua K; Mrango Z; Cotter SY; Stoller NE; O'Brien KS; Fry DM; Vanderschelden B; Oldenburg CE; West SK; Bailey RL; Keenan JD; Lietman TM;
Clin Infect Dis; 2019 May; 68(12):2114-2116. PubMed ID: 30561577
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
[TBL] [Abstract][Full Text] [Related]
13. Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.
Arzika AM; Maliki R; Goodhew EB; Rogier E; Priest JW; Lebas E; O'Brien KS; Le V; Oldenburg CE; Doan T; Porco TC; Keenan JD; Lietman TM; Martin DL; Arnold BF;
Nat Commun; 2022 Feb; 13(1):976. PubMed ID: 35190534
[TBL] [Abstract][Full Text] [Related]
14. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial.
O'Brien KS; Arzika AM; Maliki R; Amza A; Manzo F; Mankara AK; Lebas E; Cook C; Oldenburg CE; Porco TC; Arnold BF; Bertozzi S; Keenan JD; Lietman TM
Int J Epidemiol; 2022 Dec; 51(6):1775-1784. PubMed ID: 34508582
[TBL] [Abstract][Full Text] [Related]
16. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
[TBL] [Abstract][Full Text] [Related]
17. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
[TBL] [Abstract][Full Text] [Related]
18. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
[TBL] [Abstract][Full Text] [Related]
19. Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial.
Bloch EM; Munoz B; Weaver J; Mrango Z; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1311-1314. PubMed ID: 32067629
[TBL] [Abstract][Full Text] [Related]
20. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
